Histopathology‐guided mass spectrometry differentiates benign nevi from malignant melanoma

Purpose Distinguishing benign nevi from malignant melanoma using current histopathological criteria may be very challenging and is one the most difficult areas in dermatopathology. The goal of this study was to identify proteomic differences, which would more reliably differentiate between benign an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cutaneous pathology 2020-03, Vol.47 (3), p.226-240
Hauptverfasser:	Lazova, Rossitza, Smoot, Katy, Anderson, Heather, Powell, Matthew J., Rosenberg, Arlene S., Rongioletti, Franco, Pilloni, Luca, D'Hallewin, Sara, Gueorguieva, Ralitza, Tantcheva‐Poór, Iliana, Obadofin, Omobolade, Camacho, Christine, Hsi, Andy, Kluger, Harriet H., Fadare, Oluwole, Seeley, Erin H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Benign benign nevus Biopsy Child Child, Preschool Classification Diagnosis, Differential Female histopathology‐guided mass spectrometry Humans Machine Learning Male malignant melanoma Mass spectrometry Mass Spectrometry - methods Mass spectroscopy Melanoma Melanoma - diagnosis Melanoma, Cutaneous Malignant Middle Aged Nevus - diagnosis Paraffin proteomics Proteomics - methods Scientific imaging Skin cancer Skin Neoplasms - diagnosis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!